New device could reduce deadly transplant complication in blood cancer patients
NCT ID NCT05617625
First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 21 times
Summary
This study tests a device that filters out certain immune cells from donor blood before a stem cell transplant. The goal is to lower the risk of graft-versus-host disease, a serious complication where the donor cells attack the patient's body. About 50 adults with myelodysplastic syndrome will take part. The study is currently on hold.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Miami Cancer Institute
Miami, Florida, 33176, United States
Conditions
Explore the condition pages connected to this study.